Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
1 other identifier
interventional
600
1 country
1
Brief Summary
The investigator and study staff will identify, recruit and randomize Latina participants with elevated genetic and Social Determinants of Heath (SDH) risks. Within 1 week of enrollment, all Latina Aim 1 participants in both study arms will engage in three 30-minute, individual, phone-based sessions with the study team across 3 consecutive weeks
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable breast-cancer
Started Jan 2023
Typical duration for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2022
CompletedFirst Posted
Study publicly available on registry
August 2, 2022
CompletedStudy Start
First participant enrolled
January 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
March 10, 2026
March 1, 2026
4.6 years
July 29, 2022
March 7, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Empower and navigation versus SOC
Number of participants that undergo risk-based BC screening per ACS guidelines versus the control group
4 years
Empower and navigation versus SOC
Number of participants that undergo recommended genetic services versus the control group
4 years
Study Arms (2)
Arm 1
OTHEREmpowerment and Navigation
Arm 2
OTHERStandard of Care (SOC)
Interventions
Eligibility Criteria
You may qualify if:
- Aim 1
- female biological sex
- identification as Latina
- one genetic risk factor (i.e., personal history of breast cancer or family history of breast or ovarian cancer)
- one SDH risk factor, based on the American Cancer Society's definitions (e.g., perceived financial struggles; transportation difficulties; exposure to violence; housing challenges; social isolation/challenges)
- + years old, based on American Cancer Society (ACS) screening guidelines for high risk populations
- No receipt of cancer genetic counseling AND no receipt of genetic testing
- Aim 2
- female biological sex
- referral from Latina Aim 1 participants
- eligibility to obtain BC screenings, based on ACS guidelines (e.g., optional annual
- screenings at 40-44 years old, recommended annual screenings at 45-54 years old, every other year screening at 55 and older)
- self-report not attending Session #3 (as this will not be recorded by the staff)
- Aim 3
- participant from Aim 1 or
- +1 more criteria
You may not qualify if:
- Aim 3
- Not a participant from Aim 1 or
- Not a participant from Aim 2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Illinois
Chicago, Illinois, 60612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prinicipal Investigator
Study Record Dates
First Submitted
July 29, 2022
First Posted
August 2, 2022
Study Start
January 18, 2023
Primary Completion (Estimated)
September 1, 2027
Study Completion (Estimated)
September 1, 2027
Last Updated
March 10, 2026
Record last verified: 2026-03